On the last trading day of the week, we are witnessing a sell-off in the stock market. The major U.S. stock indices are recording declines today following the release of macroeconomic data at the start of the cash session. At the time of publication, the US500 index is down 0.55% to 6,100 points, the US100 is losing 0.55% to 22,000 points, and the small-cap index is down 0.95% to 2,240 points.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app
The macroeconomic data came as a surprise to investors and worsened market sentiment. First, we received preliminary PMI data, which showed a larger-than-expected decline. This time, the services sector was the main drag, while the industrial sector posted slight growth. The U.S. services sector fell to its lowest level since early 2023, signaling increasing uncertainty, a slowdown in economic activity, and rising prices. Optimism dropped from near three-year highs, with companies citing concerns over government policies, tariffs, and geopolitical risks.
The negative sentiment was further exacerbated by the later release of the University of Michigan (UoM) report, which revealed high inflation expectations among consumers. Additionally, annual GDP growth forecasts dropped to just 0.6% in February, down from over 2% last year.
This is certainly not the best combination for stock market investors, who prefer a stable environment for the growth of American businesses. And this is precisely the reaction we are seeing at the opening of today’s cash session.
US500
The index of the largest U.S. companies is down 0.55% at the start of the cash session, trading at 6,100 points. Once again, growth on the index has been effectively halted around the 6,100-point level.
Source: xStation 5
Stock market news
MercadoLibre (MELI.US) rose 7% after surpassing Q4 expectations with $6.1B in revenue, $120M above estimates. Sales grew 37.4% Y/Y, driven by an 8% GMV increase and 33% rise in payment volume. EPS soared to $12.61, nearly quadrupling from last year. Brazil, its largest market, saw 13% GMV growth and a 38% revenue jump.
Celsius Holdings (CELH.US) jumped 26% following strong Q4 earnings and its $1.8B acquisition of Alani Nu. The deal, closing in Q2, includes $900M in debt and $375M in cash. Celsius expects immediate EPS growth and $50M in cost synergies over two years, strengthening its presence in the fast-growing energy drink market.
Nu Holdings (NU.US) fell 15.3% after missing Q4 estimates, with purchase volume declining to $31.1B from $32.6B in Q3, though up from last year. The Brazilian digital bank added 5.5M customers, reaching 99.3M users, while average revenue per customer increased to $11.4 from $10.6 in Q3.
Akamai Technologies (AKAM.US) sank 15.6% as weak 2025 guidance overshadowed strong Q4 results. Projected EPS of $6.00–$6.40 and revenue of $4.0B–$4.2B missed estimates. The company also forecast an operating margin of 28%, below expectations, with Q1 revenue and EPS guidance falling short of consensus.
UnitedHealth Group (UNH.US) dropped 8.6% after reports of a DoJ fraud investigation into inflated Medicare Advantage payments. This adds to ongoing regulatory scrutiny, including a DoJ antitrust probe and a lawsuit to block its $3.3B Amedisys acquisition, raising concerns about its business practices.
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
